• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NKG2D(一种应激诱导的MICA受体)对自然杀伤细胞和T细胞的激活作用。

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

作者信息

Bauer S, Groh V, Wu J, Steinle A, Phillips J H, Lanier L L, Spies T

机构信息

Fred Hutchinson Cancer Research Center, Clinical Research Division, 1100 Fairview Avenue North, Seattle, WA 98109, USA.

出版信息

Science. 1999 Jul 30;285(5428):727-9. doi: 10.1126/science.285.5428.727.

DOI:10.1126/science.285.5428.727
PMID:10426993
Abstract

Stress-inducible MICA, a distant homolog of major histocompatibility complex (MHC) class I, functions as an antigen for gammadelta T cells and is frequently expressed in epithelial tumors. A receptor for MICA was detected on most gammadelta T cells, CD8+ alphabeta T cells, and natural killer (NK) cells and was identified as NKG2D. Effector cells from all these subsets could be stimulated by ligation of NKG2D. Engagement of NKG2D activated cytolytic responses of gammadelta T cells and NK cells against transfectants and epithelial tumor cells expressing MICA. These results define an activating immunoreceptor-MHC ligand interaction that may promote antitumor NK and T cell responses.

摘要

应激诱导的MICA是主要组织相容性复合体(MHC)I类的远亲同源物,作为γδT细胞的抗原,且在上皮肿瘤中经常表达。在大多数γδT细胞、CD8⁺αβT细胞和自然杀伤(NK)细胞上检测到MICA的一种受体,并将其鉴定为NKG2D。所有这些亚群的效应细胞都可通过NKG2D的连接而被刺激。NKG2D的结合激活了γδT细胞和NK细胞对表达MICA的转染细胞和上皮肿瘤细胞的溶细胞反应。这些结果定义了一种可能促进抗肿瘤NK和T细胞反应的激活免疫受体-MHC配体相互作用。

相似文献

1
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.NKG2D(一种应激诱导的MICA受体)对自然杀伤细胞和T细胞的激活作用。
Science. 1999 Jul 30;285(5428):727-9. doi: 10.1126/science.285.5428.727.
2
Activation of V gamma 9V delta 2 T cells by NKG2D.自然杀伤细胞2D(NKG2D)介导的Vγ9Vδ2 T细胞激活
J Immunol. 2005 Aug 15;175(4):2144-51. doi: 10.4049/jimmunol.175.4.2144.
3
An activating immunoreceptor complex formed by NKG2D and DAP10.由NKG2D和DAP10形成的一种活化免疫受体复合物。
Science. 1999 Jul 30;285(5428):730-2. doi: 10.1126/science.285.5428.730.
4
Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.人类自然杀伤细胞2D(NKG2D)与其配体MICA、MICB以及小鼠RAE - 1蛋白家族同源物之间的相互作用。
Immunogenetics. 2001 May-Jun;53(4):279-87. doi: 10.1007/s002510100325.
5
MICA/NKG2D-mediated immunogene therapy of experimental gliomas.MICA/NKG2D介导的实验性胶质瘤免疫基因治疗。
Cancer Res. 2003 Dec 15;63(24):8996-9006.
6
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.全身NKG2D下调会损害体内自然杀伤细胞(NK)和CD8 T细胞反应。
J Immunol. 2005 Jul 15;175(2):720-9. doi: 10.4049/jimmunol.175.2.720.
7
NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.NKG2D招募两种不同的衔接蛋白以触发自然杀伤细胞的激活和共刺激。
Nat Immunol. 2002 Dec;3(12):1150-5. doi: 10.1038/ni857. Epub 2002 Nov 11.
8
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.不同组织类型肿瘤细胞系上主要组织相容性复合体I类相关链A和UL16结合蛋白的表达:肿瘤对NKG2D依赖性自然杀伤细胞细胞毒性的易感性分析
Cancer Res. 2002 Nov 1;62(21):6178-86.
9
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.一种新型的NKG2D受体配体可激活自然杀伤细胞和巨噬细胞并诱导肿瘤免疫。
Eur J Immunol. 2003 Feb;33(2):381-91. doi: 10.1002/immu.200310012.
10
Regulation of cutaneous malignancy by gammadelta T cells.γδT细胞对皮肤恶性肿瘤的调控
Science. 2001 Oct 19;294(5542):605-9. doi: 10.1126/science.1063916. Epub 2001 Sep 20.

引用本文的文献

1
The Role of MICA/B Molecules and the NKG2D Receptor in the Interaction Between NK-92 Cells and JEG-3 Cells.MICA/B分子和NKG2D受体在NK-92细胞与JEG-3细胞相互作用中的作用
Int J Mol Sci. 2025 Aug 29;26(17):8400. doi: 10.3390/ijms26178400.
2
Comparative efficacy and safety of PSCA CAR-engineered Vδ1 γδ T cells for immunotherapy of pancreatic cancer.PSCA嵌合抗原受体工程化Vδ1 γδ T细胞用于胰腺癌免疫治疗的疗效和安全性比较
J Immunother Cancer. 2025 Sep 9;13(9):e011890. doi: 10.1136/jitc-2025-011890.
3
Immune surveillance of senescent cells in aging and disease.
衰老与疾病中衰老细胞的免疫监视
Nat Aging. 2025 Aug;5(8):1415-1424. doi: 10.1038/s43587-025-00910-5. Epub 2025 Aug 14.
4
Defining the genetic determinants of CD8 T cell receptor repertoire in the context of immune checkpoint blockade.在免疫检查点阻断的背景下定义CD8 T细胞受体库的遗传决定因素。
Sci Adv. 2025 Jul 25;11(30):eadu3461. doi: 10.1126/sciadv.adu3461.
5
A dual nature of γδ T cell immune memory responses.γδ T细胞免疫记忆反应的双重性质。
Elife. 2025 Jul 23;14:e104887. doi: 10.7554/eLife.104887.
6
Towards the development of next-generation lung cancer immunotherapy.迈向新一代肺癌免疫疗法的发展
Transl Lung Cancer Res. 2025 Jun 30;14(6):2257-2271. doi: 10.21037/tlcr-2024-1097. Epub 2025 Jun 25.
7
Role of Innate Immunity in Cancer.先天免疫在癌症中的作用。
Adv Exp Med Biol. 2025;1476:309-337. doi: 10.1007/978-3-031-85340-1_13.
8
CAR-T cell therapy for cancer: current challenges and future directions.用于癌症治疗的嵌合抗原受体T细胞疗法:当前挑战与未来方向
Signal Transduct Target Ther. 2025 Jul 4;10(1):210. doi: 10.1038/s41392-025-02269-w.
9
Prospects and limitations of NK cell adoptive therapy in clinical applications.自然杀伤细胞过继性治疗在临床应用中的前景与局限性
Cancer Metastasis Rev. 2025 Jun 25;44(3):57. doi: 10.1007/s10555-025-10273-3.
10
Ectopic ULBP2 Is Associated with Decreased NKG2D Expression in CD8 T Cells Under T Cell-Modulatory Conditions in a Murine Tumor Model.在小鼠肿瘤模型的T细胞调节条件下,异位ULBP2与CD8 T细胞中NKG2D表达降低有关。
Cells. 2025 Jun 13;14(12):893. doi: 10.3390/cells14120893.